Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
80086446
Market status:
Marketed
Licence Status:
Active
Brand name(s):
Potassium Iodide
Licence holder:
New Roots Herbal Inc.
Dosage Form:
Tablet
Recommended route of administration:

Oral

Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Adults 2.0 tablet 1 daily
Adults and Adolescents 4 18 year(s) 1.0 tablet 1 daily
Children 2 36 month(s) 0.5 tablet 1 daily
Recommended use or purpose:
Thyroid blocking agent for use in nuclear emergencies which involve the release of radioiodine.
Risk Information:
Cautions and Warnings 
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have Graves' disease or autoimmune thyroiditis. Breastfed infants should receive their dose of iodine by direct administration and should not rely on a protective effect from breast milk. This product is not intended for use as a generic anti-radiation drug. It is only effective for specific use during radioiodine exposure. Keep out of reach of children. This product is not intended for nutritional use
Contra-Indications 
Do not take this drug if you are allergic to iodine, have iodine sensitivity, dermatitis herpetiformis, hypocomplementemic vasculitis, or past or present history of hyperthyroidism. Do not take this medicine more often or at higher dose than directed by a health care practitioner or health care authority. More potassium iodate will not help you and may increase the risk of serious side effects.
Known Adverse Reactions 
Serious risks may be associated with the repeated use of this product. Repeated doses should be supervised by a health care practitioner. Some people may experience sialadenitis (an inflammation of the salivary glands), gastrointestinal disturbances or temporary rash. If symptoms persist or worsen, consult a health care practitioner. In case of an allergic reaction (swelling of arms, face, legs, lips, tongue, throat, difficulty in breathing, speaking or swallowing; shortness of breath and/or appearance of a severe rash or fever and joint pain), contact a healthcare practitioner or public health authority immediately.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
Potassium Iodide 65.0 milligrams
List of non-medicinal ingredients:
  • Magnesium stearate
  • Microcrystalline cellulose
Date of licensing:
2018-06-20
Revised date of licence:

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

Date modified: